Farmadec SRL
Farmadec reported total assets of 554,731 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Jul 2026).
The score of Farmadec shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets -39 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmadec's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −32,030 € | ||||
| Equity | 163,553 € | ||||
| Cash | 31,727 € | ||||
| EBITDA | 45,346 € | ||||
| Total assets | 554,731 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Jul 2026
- Year ended 31 Dec 2024filed on 15 Jul 2025
- Year ended 31 Mar 2023filed on 26 Sep 2023
- Year ended 31 Mar 2022filed on 20 Sep 2022
- Year ended 31 Mar 2021filed on 20 Sep 2021
Farmadec's financial analysis
- Solvency29.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmadec
Farmadec's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.835.274
- VAT number
- BE0896835274
- Peppol
- Registered · 0208:0896835274 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 31 Mar 2008
- Registered office
- 1730 Asse
- Latest accounts
- 2025 · filed on 14 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Farmadec (SRL) has been based in Asse since 2008, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 32,030 € and equity of 163,553 €; its revenue is not published. Its solvency stands at 29.5%, below the median of its sector (44.0%).
Companies similar to Farmadec
Companies in the same business, of comparable size and area, outside its group.
- Yapharm Retail sale of pharmaceutical products Uccle · balance sheet 436,227 €
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Vereenooghe OST Retail sale of pharmaceutical products Ostend · balance sheet 553,755 €
- Antwer Retail sale of pharmaceutical products Wervik · balance sheet 548,543 €
- Apotheek D'HEER Pharma Retail sale of pharmaceutical products Lokeren · balance sheet 563,573 €
- Avanu Retail sale of pharmaceutical products Aalst · balance sheet 544,416 €
- La Grande Pharmacie Retail sale of pharmaceutical products Thimister-Clermont · balance sheet 539,236 €
- Esperanto Retail sale of pharmaceutical products Ledegem · balance sheet 573,018 €
Frequently asked questions about Farmadec
What is the revenue of Farmadec?
Farmadec files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmadec?
In Belgium, the VAT number is the company number prefixed with BE: BE0896835274 for Farmadec, if the company is VAT-registered. Its company number (CBE) is 0896.835.274.
Where is the registered office of Farmadec?
According to the CBE register, the registered office of Farmadec is in 1730 Asse.
What is the equity of Farmadec?
At the close of the 2025 financial year, the equity of Farmadec amounts to 163,553 €, a solvency of 29.5% of total assets.
Who manages Farmadec?
The register lists 2 active mandates at Farmadec. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmadec
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →